Press Releases for 2024
Late-breaking Analysis From the remedē® System Pivotal Trial Suggests Favorable Outcomes for Heart Failure (HF) Patients With Central Sleep Apnea Receiving Phrenic Nerve Stimulation
Monday, May 13, 2024 in Chelmsford, Mass.
ZOLL Receives Innovative Technology Contract from Vizient for TherOx SuperSaturated Oxygen (SSO₂) TherapyTuesday, April 2, 2024 in Chelmsford, Mass.
ZOLL Receives FDA Clearance and CE Mark to Expand the Thermogard Platform – All-In-One Core and Surface CoolingMonday, January 8, 2024 in Chelmsford, Mass.
ZOLL one of the first to receive approval for AEDs under the EU Medical Device Regulation (MDR) CertificationThursday, February 8, 2024 in Chelmsford, Mass.